Sign in

Publications

Search in 13066 publications:

Reset RSS
Time frame
11585 Publication(s)
Jan 1, 2022
Is Hypofractionation a Good Idea in Radiotherapy for Locally Advanced NSCLC?
Putora P, De Ruysscher D. Is Hypofractionation a Good Idea in Radiotherapy for Locally Advanced NSCLC?. J Thorac Oncol 2022; 17:487-488.
Jan 1, 2022
Is Hypofractionation a Good Idea in Radiotherapy for Locally Advanced NSCLC?
Jan 1, 2022

J Thorac Oncol 2022; 17:487-488

Putora Paul Martin, De Ruysscher Dirk

more
Jan 1, 2022
EJVES - a Look Ahead
Dick F, Björck M. EJVES - a Look Ahead. Eur J Vasc Endovasc Surg 2022; 63:1-2.
Jan 1, 2022
EJVES - a Look Ahead
Jan 1, 2022

Eur J Vasc Endovasc Surg 2022; 63:1-2

Dick Florian, Björck Martin

more
Jan 1, 2022
Schwere Hypophosphatämie nach Eiseninfusion
Wimmersberger D, Mani L, Zanchin C, Kuhn C, Messi M, Günther G, Wertli M, Martin Y. Schwere Hypophosphatämie nach Eiseninfusion. Swiss Medical Forum 2022
Jan 1, 2022
Schwere Hypophosphatämie nach Eiseninfusion
Jan 1, 2022

Swiss Medical Forum 2022

Wimmersberger David, Mani Laila-Yasmin, Zanchin Christian, Kuhn Christian, Messi Mia, Günther Gunar, Wertli Maria, Martin Yonas

more
Jan 1, 2022
Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA.
Schmiedeberg K, Abela I, Pikor N, Vuilleumier N, Schwarzmueller M, Epp S, Pagano S, Grabherr S, Patterson A, Nussberger M, Trkola A, Ludewig B, von Kempis J, Rubbert-Roth A. Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA. RMD Open 2022; 8
Jan 1, 2022
Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA.
Jan 1, 2022

RMD Open 2022; 8

Schmiedeberg Kristin, Abela Irene A, Pikor Natalia, Vuilleumier Nicolas, Schwarzmueller Magdalena, Epp Selina, Pagano Sabrina, Grabherr Sarah, Patterson Angelica Brooke, Nussberger Madalina, Trkola Alexandra, Ludewig Burkhard, von Kempis Johannes, Rubbert-Roth Andrea

more
Jan 1, 2022
A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2.
Albrich W, Ghosh T, Ahearn-Ford S, Mikaeloff F, Lunjani N, Forde B, Suh N, Kleger G, Pietsch U, Frischknecht M, Garzoni C, Forlenza R, Horgan M, Sadlier C, Negro T, Pugin J, Wozniak H, Cerny A, Neogi U, O'Toole P, O'Mahony L. A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2. Gut Microbes 2022; 14:2073131.
Jan 1, 2022
A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2.
Jan 1, 2022

Gut Microbes 2022; 14:2073131

Albrich Werner, Ghosh Tarini Shankar, Ahearn-Ford Sinead, Mikaeloff Flora, Lunjani Nonhlanhla, Forde Brian, Suh Noémie, Kleger Gian-Reto, Pietsch Urs, Frischknecht Manuel, Garzoni Christian, Forlenza Rossella, Horgan Mary, Sadlier Corinna, Negro Tommaso Rochat, Pugin Jérôme, Wozniak Hannah, Cerny Andreas, Neogi Ujjwal, O'Toole Paul W, O'Mahony Liam

more
Jan 1, 2022
[Therapy of Heart Failure with Reduced Ejection Fraction: What's New in the 2021 Guidelines?].
Maeder M, Rickli H, Brenner R, Scheler E, Buser M. [Therapy of Heart Failure with Reduced Ejection Fraction: What's New in the 2021 Guidelines?]. Praxis (Bern 1994) 2022; 111:445-456.
Jan 1, 2022
[Therapy of Heart Failure with Reduced Ejection Fraction: What's New in the 2021 Guidelines?].
Jan 1, 2022

Praxis (Bern 1994) 2022; 111:445-456

Maeder Micha, Rickli Hans, Brenner Roman, Scheler Eva, Buser Marc

more
Jan 1, 2022
[Non-antibiotic Prophylaxis of Infections].
Seneghini M, Albrich W. [Non-antibiotic Prophylaxis of Infections]. Praxis (Bern 1994) 2022; 111:463-468.
Jan 1, 2022
[Non-antibiotic Prophylaxis of Infections].
Jan 1, 2022

Praxis (Bern 1994) 2022; 111:463-468

Seneghini Marco, Albrich Werner

more
Jan 1, 2022
[How Myelodysplastic Syndrome is Diagnosed].
Silzle T. [How Myelodysplastic Syndrome is Diagnosed]. Ther Umsch 2022; 78:77-85.
Jan 1, 2022
[How Myelodysplastic Syndrome is Diagnosed].
Jan 1, 2022

Ther Umsch 2022; 78:77-85

Silzle Tobias

more
Jan 1, 2022
A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial.
Abbruzzese G, Kulisevsky J, Bergmans B, Gomez-Esteban J, Kägi G, Raw J, Stefani A, Warnecke T, Jost W, SYNAPSES Study Investigators Group. A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial. J Parkinsons Dis 2022; 12:473.
Jan 1, 2022
A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial.
Jan 1, 2022

J Parkinsons Dis 2022; 12:473

Abbruzzese Giovanni, Kulisevsky Jaime, Bergmans Bruno, Gomez-Esteban Juan C, Kägi Georg, Raw Jason, Stefani Alessandro, Warnecke Tobias, Jost Wolfgang H, SYNAPSES Study Investigators Group

more
Jan 1, 2022
Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex
van Rees D, Saura C, Di Cosimo S, Huober J, Roylance R, Kim S, Kuijpers T, van Bruggen R, K van den Berg T, Guillaume S, Izquierdo M, El-Abed S, Bouti P, Klein B, Verkuijlen P, van Houdt M, Schornagel K, Tool A, Venet D, Sotiriou C, Matlung H. Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex. J Immunother Cancer 2022; 10
Jan 1, 2022
Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex
Jan 1, 2022

J Immunother Cancer 2022; 10

van Rees Dieke J, Saura Cristina, Di Cosimo Serena, Huober Jens, Roylance Rebecca, Kim Sung-Bae, Kuijpers Taco W, van Bruggen Robin, K van den Berg Timo, Guillaume Sébastien, Izquierdo Miguel, El-Abed Sarra, Bouti Panagiota, Klein Bart, Verkuijlen Paul J H, van Houdt Michel, Schornagel Karin, Tool Anton T J, Venet David, Sotiriou Christos, Matlung Hanke L

more
Jan 1, 2022
Effect of Denosumab Added to 2 Different nab-Paclitaxel Regimens as Neoadjuvant Therapy in Patients With Primary Breast Cancer: The GeparX 2 × 2 Randomized Clinical Trial
Blohmer J, Jackisch C, Rhiem K, Solbach C, Hanusch C, Seither F, Denkert C, Engels K, Nekljudova V, Loibl S, Thill M, Huober J, Link T, Reinisch M, Just M, Untch M, Stötzer O, Fasching P, Schneeweiss A, Wimberger P, Seiler S, GBG and AGO-B. Effect of Denosumab Added to 2 Different nab-Paclitaxel Regimens as Neoadjuvant Therapy in Patients With Primary Breast Cancer: The GeparX 2 × 2 Randomized Clinical Trial. JAMA Oncol 2022; 8:1010-1018.
Jan 1, 2022
Effect of Denosumab Added to 2 Different nab-Paclitaxel Regimens as Neoadjuvant Therapy in Patients With Primary Breast Cancer: The GeparX 2 × 2 Randomized Clinical Trial
Jan 1, 2022

JAMA Oncol 2022; 8:1010-1018

Blohmer Jens-Uwe, Jackisch Christian, Rhiem Kerstin, Solbach Christine, Hanusch Claus, Seither Fenja, Denkert Carsten, Engels Knut, Nekljudova Valentina, Loibl Sibylle, Thill Marc, Huober Jens, Link Theresa, Reinisch Mattea, Just Marianne, Untch Michael, Stötzer Oliver, Fasching Peter A, Schneeweiss Andreas, Wimberger Pauline, Seiler Sabine, GBG and AGO-B

more
Jan 1, 2022
Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel).
Mueller R, Schulze-Koops H, Furst D, Cohen S, Kwok K, Wang L, Killeen T, von Kempis J. Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel). Clin Rheumatol 2022; 41:1045-1055.
Jan 1, 2022
Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel).
Jan 1, 2022

Clin Rheumatol 2022; 41:1045-1055

Mueller Ruediger B, Schulze-Koops Hendrik, Furst Daniel E, Cohen Stanley B, Kwok Kenneth, Wang Lisy, Killeen Tim, von Kempis Johannes

more
Dec 30, 2021
Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials
Burmester G, Liu J, Mccaskill R, Lertratanakul A, Lippe R, Lesser E, Rubbert-Roth A, Salvarani C, Azevedo V, Goupille P, Nash P, Blanco R, Winthrop K, Ruderman E. Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials. Rheumatol Ther 2021
Dec 30, 2021
Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials
Dec 30, 2021

Rheumatol Ther 2021

Burmester Gerd R, Liu John, Mccaskill Reva M, Lertratanakul Apinya, Lippe Ralph, Lesser Elizabeth, Rubbert-Roth Andrea, Salvarani Carlo, Azevedo Valderilio F, Goupille Philippe, Nash Peter, Blanco Ricardo, Winthrop Kevin, Ruderman Eric M

more
Dec 29, 2021
Spinous-Process-Splitting Versus Conventional Decompression for Lumbar Spinal Stenosis: Comparative Study with Respect to Short-Term Postoperative Pain and Analgesics Use.
Voglis S, Tosic L, Höbner L, Hofer A, Stienen M, Regli L, Bellut D, Dias S. Spinous-Process-Splitting Versus Conventional Decompression for Lumbar Spinal Stenosis: Comparative Study with Respect to Short-Term Postoperative Pain and Analgesics Use. World Neurosurg 2021; 160:e80-e87.
Dec 29, 2021
Spinous-Process-Splitting Versus Conventional Decompression for Lumbar Spinal Stenosis: Comparative Study with Respect to Short-Term Postoperative Pain and Analgesics Use.
Dec 29, 2021

World Neurosurg 2021; 160:e80-e87

Voglis Stefanos, Tosic Lazar, Höbner Lara Maria, Hofer Anna-Sophie, Stienen Martin, Regli Luca, Bellut David, Dias Sandra Fernandes

more
Dec 27, 2021
The Simultaneous Presence of Isolated Tumour Cells and Bone Marrow Micrometastases in Stage I and II Colon Cancer-Challenging the Theory of a Chronological Pathway of Tumour Cell Dissemination
Ramser M, Warschkow R, Viehl C, Kettelhack C, Zettl A, Lobbes L, Zuber M, Weixler B. The Simultaneous Presence of Isolated Tumour Cells and Bone Marrow Micrometastases in Stage I and II Colon Cancer-Challenging the Theory of a Chronological Pathway of Tumour Cell Dissemination. World J Surg 2021
Dec 27, 2021
The Simultaneous Presence of Isolated Tumour Cells and Bone Marrow Micrometastases in Stage I and II Colon Cancer-Challenging the Theory of a Chronological Pathway of Tumour Cell Dissemination
Dec 27, 2021

World J Surg 2021

Ramser Michaela, Warschkow Rene, Viehl Carsten T, Kettelhack Christoph, Zettl Andreas, Lobbes Leonard A, Zuber Markus, Weixler Benjamin

more
Dec 27, 2021
European Stroke Organisation Conference 2021 Plenary Highlights.
Chun H, Dittrich T, Øygarden H, Li L. European Stroke Organisation Conference 2021 Plenary Highlights. Stroke 2021; 53:e21-e22.
Dec 27, 2021
European Stroke Organisation Conference 2021 Plenary Highlights.
Dec 27, 2021

Stroke 2021; 53:e21-e22

Chun Ho-Yan Yvonne, Dittrich Tolga, Øygarden Halvor, Li Linxin

more
Dec 23, 2021
Long-term follow-up of medically treated patients with spontaneous coronary artery dissection: a prospective, Swiss single-centre cohort study
Seidl S, Rigger J, Chronis J, Rohner F, Jörg L, Haager P, Ammann P, Weilenmann D, Rogowski S, Rickli H, Maeder M. Long-term follow-up of medically treated patients with spontaneous coronary artery dissection: a prospective, Swiss single-centre cohort study. Swiss Med Wkly 2021; 151:w30067.
Dec 23, 2021
Long-term follow-up of medically treated patients with spontaneous coronary artery dissection: a prospective, Swiss single-centre cohort study
Dec 23, 2021

Swiss Med Wkly 2021; 151:w30067

Seidl Sebastian, Rigger Johannes, Chronis Joannis, Rohner Franziska, Jörg Lucas, Haager Philipp K., Ammann Peter, Weilenmann Daniel, Rogowski Sebastian, Rickli Hans, Maeder Micha

more
Dec 23, 2021
Prediction of Acute COPD Exacerbation in the Swiss Multicenter COPD Cohort Study (TOPDOCS) by Clinical Parameters, Medication Use, and Immunological Biomarkers
Huebner S, Leuppi-Taegtmeyer A, Kohler M, Trendelenburg M, Thurnheer R, Sievi N, Irani S, Heijnen I, Frey M, Egli A, Dieterle T, Clarenbach C, Chhajed P, Brutsche M, Brack T, Giezendanner S, Henny S, Leuppi J. Prediction of Acute COPD Exacerbation in the Swiss Multicenter COPD Cohort Study (TOPDOCS) by Clinical Parameters, Medication Use, and Immunological Biomarkers. Respiration 2021:1-14.
Dec 23, 2021
Prediction of Acute COPD Exacerbation in the Swiss Multicenter COPD Cohort Study (TOPDOCS) by Clinical Parameters, Medication Use, and Immunological Biomarkers
Dec 23, 2021

Respiration 2021:1-14

Huebner Simona Tabea, Leuppi-Taegtmeyer Anne Barbara, Kohler Malcolm, Trendelenburg Marten, Thurnheer Robert, Sievi Noriane Andrina, Irani Sarosh, Heijnen Ingmar, Frey Martin, Egli Adrian, Dieterle Thomas, Clarenbach Christian, Chhajed Prashant, Brutsche Martin, Brack Thomas, Giezendanner Stéphanie, Henny Simona, Leuppi Joerg Daniel

more
Dec 22, 2021
Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline.
Daly M, Singh N, Ismaila N, Antonoff M, Arenberg D, Bradley J, David E, Detterbeck F, Früh M, Gubens M, Moore A, Padda S, Patel J, Phillips T, Qin A, Robinson C, Simone C. Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline. J Clin Oncol 2021; 40:1356-1384.
Dec 22, 2021
Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline.
Dec 22, 2021

J Clin Oncol 2021; 40:1356-1384

Daly Megan E, Singh Navneet, Ismaila Nofisat, Antonoff Mara B, Arenberg Douglas A, Bradley Jeffrey, David Elizabeth, Detterbeck Frank, Früh Martin, Gubens Matthew A, Moore Amy C, Padda Sukhmani K, Patel Jyoti D, Phillips Tanyanika, Qin Angel, Robinson Clifford, Simone Charles B

more
Dec 22, 2021
Differences Between Anticoagulated Patients With Ischemic Stroke Versus Intracerebral Hemorrhage.
Schaub F, Polymeris A, Schaedelin S, Hert L, Meya L, Thilemann S, Traenka C, Wagner B, Seiffge D, Gensicke H, De Marchis G, Bonati L, Engelter S, Peters N, Lyrer P. Differences Between Anticoagulated Patients With Ischemic Stroke Versus Intracerebral Hemorrhage. J Am Heart Assoc 2021; 11:e023345.
Dec 22, 2021
Differences Between Anticoagulated Patients With Ischemic Stroke Versus Intracerebral Hemorrhage.
Dec 22, 2021

J Am Heart Assoc 2021; 11:e023345

Schaub Fabian, Polymeris Alexandros A, Schaedelin Sabine A, Hert Lisa, Meya Louisa, Thilemann Sebastian, Traenka Christopher, Wagner Benjamin, Seiffge David Julian, Gensicke Henrik, De Marchis Gian Marco, Bonati Leo H, Engelter Stefan T, Peters Nils, Lyrer Philippe A

more

We use cookies and tracking technologies according to our privacy policy to provide you with the best possible web experience. To the privacy policy